Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Lower SHBG levels may increase the risk of PCOS.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.